Each year in the United States, approximately 440,000 persons die of a cigarette smoking-attributable illness, resulting in 5.6 million years of potential life lost, $75 billion in direct medical costs, and $82 billion in lost productivity.1
To assess smoking-attributable morbidity, Roswell Park Cancer Institute, Research Triangle Institute, and the Centers for Disease Control and Prevention analyzed data from three sources: the Behavioral Risk Factor Surveillance System (BRFSS), the National Health and Nutrition Examination Survey III (NHANES III), and the US Census.
This report summarizes the results of that analysis, which indicate that an estimated 8.6 million persons in the United States have serious illnesses attributed to smoking; chronic bronchitis and emphysema account for 59% of all smoking-attributable diseases.
These findings underscore the need to expand surveillance of the disease burden caused by smoking and to establish comprehensive tobacco-use prevention and cessation efforts to reduce the adverse health impact of smoking.
Data on the number of persons by sex, age group (18–34, 35–49, 50–64, and 65 and over), and race (white or other race) for each state and the District of Columbia were obtained from the 2000 US Census.
National estimates of the prevalence of current, former, and never smokers were derived from the combined data from the 1999, 2000, and 2001 BRFSS surveys.
Current smokers were defined as persons who reported smoking more than 100 cigarettes during their lifetime and who now smoke some days or every day.
Former smokers were defined as persons who reported having smoked more than 100 cigarettes during their lifetime but did not smoke at the time of interview. Never smokers were defined as persons who reported having smoked fewer than 100 cigarettes during their lifetime.
Estimates of the prevalence of smoking-related conditions were obtained from the NHANES III survey for 1988–1994 for current, former, and never smokers for each demographic group to estimate the smoking-attributable fractions of morbid conditions.
The smoking-related conditions for which data were collected are those categorized by the US Surgeon General as caused by smoking2 and addressed in NHANES III.
Respondents reported whether a “doctor ever told” them if they had any of the following conditions: stroke, heart attack, emphysema, chronic bronchitis, and specific cancer types, including lung, bladder, mouth/pharynx, esophagus, cervix, kidney, larynx, or pancreas.
Smoking-attributable morbidity estimates were obtained in two ways. For one estimate, each person was considered as the unit of analysis, and persons with at least one smoking-related condition were counted as having a condition.
For the second estimate, the condition was treated as the unit of analysis, so persons with multiple conditions were counted more than once. Estimates were derived separately for each condition, and the total of all conditions was summed.
The number of persons with a smoking-attributable morbid condition was estimated by state and demographic subpopulations from the following five steps:
* BRFSS smoking status estimates by demographic group were applied to census data to estimate the number of current, former, and never smokers in each demographic group in each state.
* NHANES III smoking-related disease frequency data were applied to the numbers from the first step to estimate the number of adults with a smoking-related condition.
* Attributable fractions for current and former smokers in each demographic group were multiplied by the number of persons with a smoking-related disease to yield an estimate of the number of persons with a disease that is attributable to smoking.
* The numbers obtained from the third step were summed across all demographic categories in each state to yield an estimate of persons with smoking-attributable conditions in each state.
* The numbers of smoking-attributable morbid conditions obtained in each state from step four were summed to yield an overall US estimate. Survey design-adjusted variance estimates were calculated for each smoking and disease prevalence by using SUDAAN. The variance estimate for the attributable fraction was calculated by using standard methodology,3 and a joint 95% confidence interval (CI) was obtained for each attributable fraction by using Bonferroni's adjustment method.4
In 2000, an estimated 8.6 million (95% CI = 6.9 million to 10.5 million) persons in the United States had an estimated 12.7 million (95% CI = 10.8 million to 15.0 million) smoking-attributable conditions.
For current smokers, chronic bronchitis was the most prevalent (49%) condition, followed by emphysema (24%). For former smokers, the three most prevalent conditions were chronic bronchitis (26%), emphysema (24%), and previous heart attack (24%).
Lung cancer accounted for 1% of all cigarette smoking-attributable illnesses.
First National Estimates
This report provides the first national estimates of the number of persons with serious chronic illnesses caused by smoking and the total number of their smoking-attributable conditions.
The findings indicate that more persons are harmed by tobacco use than is indicated by mortality estimates. Examining trends in tobacco-attributable morbidity provides another way to monitor the progress of tobacco-control efforts.
Smoking-attributable mortality estimates published in 20021 differ from the estimates described in this report. Mortality data indicate the number of persons who die of a disease each year, and morbidity data from this study are used to estimate the prevalence of persons living with diseases caused by smoking at a point in time.
In addition, mortality estimates are based on official cause of death data and smoking-attributable fractions derived from data from the Cancer Prevention Study II, and the smoking-attributable morbidity fractions in this study are based solely on self-reported survey data on diseases addressed in NHANES III.
The findings in this report are subject to at least three limitations. First, the estimates do not adjust for potential confounders (e.g., diet, exercise, or geography) other than age, sex, and race/ethnicity.
The impact of confounding was examined in a prospective cohort study of approximately one million persons; findings indicated that adjusting for several demographic, behavioral, medical, and occupational factors reduced the smoking attributable mortality estimate by only 2.5%.
However, no analyses have been performed that examine smoking-attributable morbidity or that use a broader range of potential confounders.5
Second, disease data are self-reported and might not represent the true rate or type of disease. A Canadian study found that the rate of underreporting of the chronic conditions cancer, stroke, and hypertension was approximately two times greater than the rate of overreporting.6
In addition, 63% of NHANES III respondents with documented low-lung function (forced expiratory volume in 1 second was less than 80% of the predicted value) did not self-report any diagnosis of obstructive lung disease.7 Therefore, these self-reported data are probably substantial underestimates of a true disease burden.
Finally, the scope of diseases considered in this report was limited to those diseases for which survey data were available and those for which the Surgeon General implicated smoking as the cause.
Various additional chronic and acute conditions affect quality of life and are caused by cigarette smoking. Inclusion of additional diseases would increase the amount of morbidity attributable to smoking.
The findings in this report complement CDC mortality data and estimates of the number of adults with chronic diseases caused by smoking.
Approximately 10% of all current and former adult smokers have a smoking-attributable chronic disease. Many of these persons are already experiencing decreased quality of life, and society will likely bear substantial direct and indirect economic costs from these diseases.1
More persons will experience serious chronic diseases attributable to smoking if they continue to smoke.8
This report underscores the need to expand the implementation of proven strategies to reduce tobacco use such as increasing the cost of cigarettes, increasing clean indoor air regulations, and implementing comprehensive tobacco-use prevention and cessation programs.